Autolus Therapeutics annual revenue
2016
2017
2018
2019
2022
2023
2024
2025
Autolus Therapeutics Revenue Growth & History (AUTL)
Autolus Therapeutics reported $75.4M in revenue for fiscal 2025, an increase of 644.94% from the previous fiscal year.
View full Autolus Therapeutics company overviewAutolus Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $75.4M | $65.3M | +644.94% |
| 2024 | 2024-12-31 | $10.1M | $8.4M | +496.00% |
| 2023 | 2023-12-31 | $1.7M | −$4.5M | −72.59% |
| 2022 | 2022-12-31 | $6.2M | — | — |
| 2019 | 2019-12-31 | $2.9M | — | — |
| 2018 | 2018-09-30 | $1.4M | −$286,000 | −16.89% |
| 2017 · Sep 30 | 2017-09-30 | $1.7M | $481,000 | +39.69% |
| 2016 | 2016-09-30 | $1.2M | — | — |
Autolus Therapeutics quarterly revenue
Q4.17
Q2.18
Q4.18
Q1.19
Q2.19
Q3.19
Q3.19
Q4.19
Q1.20
Q2.20
Q1.21
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $45.7M | $24.8M | +118.37% |
| Q1 2026 | 2026-03-31 | $26.2M | $17.2M | +191.89% |
| Q4 2025 | 2025-12-31 | $24.3M | $24.3M | +83655.17% |
| Q3 2025 | 2025-09-30 | $21.2M | $21.2M | — |
| Q2 2025 | 2025-06-30 | $20.9M | $20.9M | — |
| Q1 2025 | 2025-03-31 | $9.0M | −$1.1M | −10.99% |
| Q4 2024 | 2024-12-31 | $29,000 | — | — |
| Q3 2024 | 2024-09-30 | $0 | — | — |
| Q2 2024 | 2024-06-30 | $0 | — | — |
| Q1 2024 | 2024-03-31 | $10.1M | — | — |
| Q1 2021 | 2021-03-31 | $269,000 | −$69,000 | −20.41% |
| Q2 2020 | 2020-06-30 | $293,000 | −$45,000 | −13.31% |
| Q1 2020 | 2020-03-31 | $338,000 | −$1.6M | −82.79% |
| Q4 2019 | 2019-12-31 | $309,000 | $13,000 | +4.39% |
| Q3 2019 · Sep 30 | 2019-09-30 | $297,000 | −$10,000 | −3.26% |
| Q3 2019 · Jun 30 | 2019-06-30 | $338,000 | −$105,000 | −23.70% |
| Q2 2019 | 2019-03-31 | $2.0M | — | — |
| Q1 2019 | 2018-12-31 | $296,000 | $65,000 | +28.14% |
| Q4 2018 | 2018-09-30 | $307,000 | — | — |
| Q2 2018 | 2018-06-30 | $443,000 | — | — |
| Q4 2017 | 2017-12-31 | $231,000 | — | — |
Autolus Therapeutics revenue growth trends
Autolus Therapeutics's latest reported quarter, Q2 2026, generated $45.7M in revenue, an increase of 118.37% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Autolus Therapeutics source filings ↗